Literature DB >> 9377907

The Danish prescription registries.

D Gaist1, H T Sørensen, J Hallas.   

Abstract

The extensive computerisation of Danish pharmacies has permitted the establishment of two large prescription registries: The Odense University Pharmacoepidemiological Database (OPED) and the Pharmacoepidemiological Prescription Database of North Jutland (PDNJ). The Danish prescription registries content, coverage, completeness and the quality of the data are discussed in this article. Furthermore, conditions for access to the data are presented. The two prescription registries cover a background population of approximately one million or 18% of the Danish population. The populations covered by the registries are stable and representative of the Danish population in general. The registries cover all reimbursed medicine at the level of the individual user. Registration of a unique and permanent personal identifier enables the compilation of longitudinal drug histories and allows the linking of prescription data to other population-based Danish registries. The degree of completeness of the Danish prescription registries is excellent for reimbursed prescription drugs. A small number of comparison studies also indicate high validity of the register information. The Danish prescription registries represent a useful new data source for pharmacoepidemiological studies.

Mesh:

Year:  1997        PMID: 9377907

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


  164 in total

1.  Polypharmacy in general practice: differences between practitioners.

Authors:  L Bjerrum; J Søgaard; J Hallas; J Kragstrup
Journal:  Br J Gen Pract       Date:  1999-03       Impact factor: 5.386

2.  Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study.

Authors:  M L Norgaard; S S Andersen; T K Schramm; F Folke; C H Jørgensen; M L Hansen; C Andersson; D M Bretler; A Vaag; L Køber; C Torp-Pedersen; G H Gislason
Journal:  Diabetologia       Date:  2010-05-09       Impact factor: 10.122

3.  Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study.

Authors:  Annmarie Lassen; Jesper Hallas; Ove B Schaffalitzky de Muckadell
Journal:  BMJ       Date:  2003-09-13

4.  Socio-economic inequalities in first-time use of antidepressants: a population-based study.

Authors:  D G Hansen; J Søndergaard; W Vach; L F Gram; J U Rosholm; P B Mortensen; J Kragstrup
Journal:  Eur J Clin Pharmacol       Date:  2004-02-17       Impact factor: 2.953

5.  Pharmaceutical interventions on prescription problems in a Danish pharmacy setting.

Authors:  Anton Pottegård; Jesper Hallas; Jens Søndergaard
Journal:  Int J Clin Pharm       Date:  2011-11-15

6.  L-type calcium channel blockers and Parkinson disease in Denmark.

Authors:  Beate Ritz; Shannon L Rhodes; Lei Qian; Eva Schernhammer; Jørgen H Olsen; Søren Friis
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

7.  Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.

Authors:  Kathrine Rugbjerg; Søren Friis; Thomas L Jørgensen; Beate Ritz; Lise Korbo; Jørgen H Olsen
Journal:  Mov Disord       Date:  2010-10-30       Impact factor: 10.338

8.  Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.

Authors:  Morten L Hansen; Gunnar H Gislason; Lars Køber; Tina Ken Schramm; Fredrik Folke; Pernille Buch; Steen Z Abildstrom; Mette Madsen; Søren Rasmussen; Christian Torp-Pedersen
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

9.  The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care.

Authors:  Michael Due Larsen; Mette Schou; Anja Sparre Kristiansen; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2014-04-27       Impact factor: 2.953

10.  Palivizumab Exposure and the Risk of Autoimmune Disease: A Cross-National Cohort Study.

Authors:  Ann Haerskjold; Marie Linder; Lonny Henriksen; Simon Francis Thomsen; Helle Kieler; Henrik Ravn; Lone Graff Stensballe
Journal:  Paediatr Drugs       Date:  2016-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.